WED-491 Longitudinal validation of the AGA, AASLD and EASL care pathways for metabolic dysfunction-associated steatotic liver disease (masld) in a prospective cohort of individuals with type 2 diabetes
Year: 2025
Type: conference-abstract
Source: Journal of Hepatology
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410173797
